Trial updateRetina
A First-In-Human Study of ARO-033 in Adult Participants
Recruiting. Phase 1. Registered enrolment: 84. Arrowhead Pharmaceuticals
Why it matters
Track this study through NCT07662096. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 1
- Registered enrolment
- 84
- Results posted
- No
- Sponsor
- Arrowhead Pharmaceuticals
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.